Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Minnesota COVID-19 Testing Project

NCT04568889 · View on ClinicalTrials.gov ↗

Study Summary

The goal of this project is to help the state of Minnesota understand why individuals are not getting tested and potentially identify trusted individuals or organizations that could be used in follow-up work to send messages. Investigators focus on the first two issues of unit and item nonresponse, which is not random across the population and thus could lead to nonresponse bias. To do so, investigators are deploying flyers through 10 Twin City area food shelves and potentially through public housing units with information on how to answer an online questionnaire.

Interventions

  • BEHAVIORAL A $10 Survey Incentive
  • BEHAVIORAL A $20 Survey Incentive
  • BEHAVIORAL Emphasis of Government Involvement
  • BEHAVIORAL Emphasis of Academic Researchers Involvement
  • BEHAVIORAL Cost-Benefit Frame

Study Locations (10)

Minnesota

  • Volunteers Enlisted to Assist People — Bloomington
  • Southern Anoka Community Assistance — Columbia Heights
  • People Reaching Out to People Food Shelf — Eden Prairie
  • Fridley Covenant Church — Fridley
  • Calvary Lutheran Church Food Shelf — Minneapolis
  • NorthPoint Health and Wellness — Minneapolis
  • Community Emergency Assistance Programs — Minneapolis
  • Intercongregation Communities Association — Minnetonka
  • Valley Outreach — Stillwater
  • White Bear Area Foodshelf — White Bear Lake

Trial Details

FieldValue
Enrollment Target 561 participants
Start Date 2020-09-28
Est. Completion 2022-08-31
Phase NA

Sponsor

Harvard University

39 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04568889

The ClinicalTrials.gov registry entry for NCT04568889 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 561 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard University, which has 39 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 2 conditions, with Covid19 appearing as the primary indexed condition, and to 5 interventions — of which A $10 Survey Incentive is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT04568889 reports 10 study locations spanning 1 distinct geographic area — top geographies include Minnesota. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT04568889 about?

NCT04568889 is a clinical study titled "Minnesota COVID-19 Testing Project". The goal of this project is to help the state of Minnesota understand why individuals are not getting tested and potentially identify trusted individuals or organizations that could be used in follow-up work to send messages. Investigators focus on the first two issues of unit and item nonresponse, ...

What is the current status of trial NCT04568889?

This trial is currently completed. It is a NA study. The enrollment target is 561 participants. The study started on 2020-09-28. Estimated completion is 2022-08-31.

What conditions does trial NCT04568889 study?

This clinical trial studies the following conditions: Covid19, Infectious Disease. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT04568889?

The interventions under investigation include: A $10 Survey Incentive (BEHAVIORAL), A $20 Survey Incentive (BEHAVIORAL), Emphasis of Government Involvement (BEHAVIORAL), Emphasis of Academic Researchers Involvement (BEHAVIORAL), Cost-Benefit Frame (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT04568889?

This trial is sponsored by Harvard University, which has 39 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT04568889 being conducted?

This trial has 10 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial